George Medicines Logo.JPG
George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III development program
August 06, 2024 07:00 ET | George Medicines
George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III development program ...
George Medicines Logo.JPG
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
April 29, 2024 07:00 ET | George Medicines
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director London, UK 29 April 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet...
Research Nester Logo.jpg
Noradrenergic Drug Market revenue to hit USD 23.3 Billion by 2035, says Research Nester
August 31, 2023 05:30 ET | Research Nester
New York, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The global noradrenergic drug market size is predicted to expand at ~3% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD...
Global Coronary Artery Disease (CAD) Market
Global Coronary Artery Disease (CAD) Market Analysis/Forecast Report 2023-2028 Featuring AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, Merck & Co, Viatris, Sanofi, & Amgen
May 15, 2023 07:53 ET | Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease (CAD) Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
AMR Logo.png
Digital Sphygmomanometer Market Is Predicted to Reach USD 1,560.50 Million by 2031: Says Allied Market Research
January 25, 2023 07:32 ET | Allied Market Research
Portland, OR, Jan. 25, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global digital sphygmomanometer market was estimated at $942.55 million in 2021 and...
22157.jpg
Worldwide Diltiazem Industry to 2028 - Increase in Cardiovascular Disease Incidence is Driving Growth
October 21, 2021 06:58 ET | Research and Markets
Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Capsules, Injection, and Tablets); Application (Angina,...
Know Your Kidneys™:
Know Your Kidneys™: American Kidney Fund Launches National Campaign to Prevent and Slow Down Kidney Disease
November 06, 2019 09:30 ET | American Kidney Fund
ROCKVILLE, Md., Nov. 06, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched a new national campaign, Know Your Kidneys™, to empower individuals to fulfill their life’s...
LIVE WELL PROVED IT: BLOOD PRESSURE REDUCTION
Canadian company proves exercise is a miracle drug
November 22, 2018 12:23 ET | LIVE WELL Exercise Clinic
Gym members see significant reductions in blood pressure, weight within 6 months of joining powerful exercise and healthy lifestyle coaching program VANCOUVER, British Columbia, Nov. 22, 2018 ...
Stanford Nephrology
Stanford Nephrology Fellow Katherine M. Wang Named American Kidney Fund Clinical Scientist in Nephrology
July 10, 2018 15:47 ET | American Kidney Fund
ROCKVILLE, Md., July 10, 2018 (GLOBE NEWSWIRE) -- Katherine M. Wang, M.D., a second-year nephrology fellow at Stanford University, has been named the American Kidney Fund (AKF) Clinical Scientist...
UPMC PINNACLE PARTIC
UPMC PINNACLE PARTICIPATING IN GROUNDBREAKING TRIAL TO HELP LOWER BLOOD PRESSURE
May 09, 2018 09:00 ET | UPMC Pinnacle
HARRISBURG, PA, May 09, 2018 (GLOBE NEWSWIRE) -- UPMC Pinnacle today announced it is enrolling patients to participate in a study of an investigational medical device that aims to help lower blood...